Invention Grant
- Patent Title: Recombinant Hansenula polymorpha-based high dosage hepatitis B vaccine
-
Application No.: US16088255Application Date: 2017-03-16
-
Publication No.: US10821174B2Publication Date: 2020-11-03
- Inventor: Hemu Wang , Changhua Wang , Jun Yang
- Applicant: Hemu Wang
- Applicant Address: CN Tianjin
- Assignee: Hemu Wang
- Current Assignee: Hemu Wang
- Current Assignee Address: CN Tianjin
- Agency: Li & Cai Intellectual Property (USA) Office
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@6b1a7731
- International Application: PCT/CN2017/076929 WO 20170316
- International Announcement: WO2017/162090 WO 20170928
- Main IPC: A61K39/29
- IPC: A61K39/29 ; C12N9/88 ; A61K39/12 ; A61P31/20 ; A61K39/39 ; C07K14/02 ; C12R1/78 ; A61K39/00
Abstract:
Provided is a recombinant Hansenula polymorpha-based high dosage hepatitis B vaccine, an HBsAg pure stock solution yield of a recombinant Hansenula polymorpha fermentation broth used for producing the hepatitis B vaccine being 300 mg/L-400 mg/L.
Public/Granted literature
- US20190083608A1 RECOMBINANT HANSENULA POLYMORPHA-BASED HIGH DOSAGE HEPATITIS B VACCINE Public/Granted day:2019-03-21
Information query
